Filing Details
- Accession Number:
- 0001213900-19-027008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-26 16:31:33
- Reporting Period:
- 2019-12-20
- Accepted Time:
- 2019-12-26 16:31:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1218683 | Wize Pharma Inc. | WIZP | Pharmaceutical Preparations (2834) | 880445167 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1723667 | Brian Jonathan Rubini | 813 D Street Anchorage AK 99501 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-12-20 | 2,037,037 | $0.27 | 2,455,739 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants | Acquisiton | 2019-12-20 | 4,074,047 | $0.00 | 4,074,047 | $0.27 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,074,047 | 2024-12-19 | No | 4 | P | Direct |
Footnotes
- Exercisable five days following the public announcement of positive clinical data results for LO2A